Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant ; volume:3 ; number:1 ; day:24 ; month:3 ; year:2015 ; pages:1-4 ; date:12.2015
Journal for ImmunoTherapy of Cancer ; 3, Heft 1 (24.3.2015), 1-4, 12.2015
- Creator
-
Cecchini, Michael
- Contributor
-
Sznol, Mario
Seropian, Stuart
SpringerLink (Online service)
- DOI
-
10.1186/s40425-015-0054-4
- URN
-
urn:nbn:de:1111-201610305259
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cecchini, Michael
- Sznol, Mario
- Seropian, Stuart
- SpringerLink (Online service)
Other Objects (12)
Clinical trial participation predicts improved survival in older adults receiving allogeneic blood and marrow transplant
Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients
METASTATIC MALIGNANT MELANOMA OF SKIN
A marker chromosome in post-transplant bone marrow
Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation
Metastatic malignant melanoma in bone marrow with occult primary site – a case report with review of literature
Unusual gingival actinomycosis post allogeneic hematopoietic stem-cell transplant: case report
Physical performance of allogeneic stem cell transplant candidates prior to transplantation
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
Clinical trial participation predicts improved survival in older adults receiving allogeneic blood and marrow transplant
Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients
METASTATIC MALIGNANT MELANOMA OF SKIN
A marker chromosome in post-transplant bone marrow
Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation
Metastatic malignant melanoma in bone marrow with occult primary site – a case report with review of literature
Unusual gingival actinomycosis post allogeneic hematopoietic stem-cell transplant: case report
Physical performance of allogeneic stem cell transplant candidates prior to transplantation
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
Clinical trial participation predicts improved survival in older adults receiving allogeneic blood and marrow transplant
Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients
METASTATIC MALIGNANT MELANOMA OF SKIN
A marker chromosome in post-transplant bone marrow
Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation
Metastatic malignant melanoma in bone marrow with occult primary site – a case report with review of literature
Unusual gingival actinomycosis post allogeneic hematopoietic stem-cell transplant: case report
Physical performance of allogeneic stem cell transplant candidates prior to transplantation
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia